0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position:Home > ACROConnect Workshop Series > Empowering the Research and Drug Development of Biomedicine
Empowering the Research and Drug Development of Biomedicine

Ex:Join our ACROConnect Workshop at Novartis Campus in Basel, Switzerland to discuss solutions and technology behind the drug development process with speakers from YuMAB, University Bern, and more. Check out more details below.

Location:Novartis Pavillon Basel, Switzerland
Date & Time: September 24th, 2024, 8:30AM - 4:15PM

EX:Food and drinks will be served, PLUS we will have lots of ACRO goodies including the coveted Llama!

Photo gallery

 Empowering the Research and Drug Development of Biomedicine

 Empowering the Research and Drug Development of Biomedicine

 Empowering the Research and Drug Development of Biomedicine

 Empowering the Research and Drug Development of Biomedicine

 Empowering the Research and Drug Development of Biomedicine

 Empowering the Research and Drug Development of Biomedicine

 Empowering the Research and Drug Development of Biomedicine

 Empowering the Research and Drug Development of Biomedicine

Meet the Speakers

Dr. Philipp Kuhn

Dr. Philipp Kuhn
YUMAB

Barbara Lösch

Dr. Barbara Lösch
Medigene

Ebru Aydin Kurtulmus

Dr. Ebru Aydin Kurtulmus
Pepperprint

NanoTemper

Dr. Gianluca Russo
NanoTemper

Amiq Gazdhar

Dr. Amiq Gazdhar
University of Bern

Idil Arioz

Dr. Idil Arioz
ACROBiosystems

Anil Kumar

Dr. Anil Kumar
ACROBiosystems

DACH Symposium 2024: Empowering the Research and Drug Development of Biomedicine

TimelineSessionSpeaker
8:30 – 9:25Registration, Coffee & Networking
9:25– 9:30Welcome Opening
9:30 – 10:00Talk 1: Advancing Drug Development and Disease Modeling with Human iPSC-derived OrganoidsDr. Idil Arioz - ACROBiosystems
10:00 – 10:45Talk 2: Lung fibrosis, repair and regeneration of scared lung. Dr. Amiq Gazdhar – University of Bern
10:45 – 11:00Coffee Break
11:00 -11:30Talk 3: UniTope and TraCR: a universal tagging and tracking system for recombinant TCR-T cells.Dr. Barbara Lösch - Medigene
11:30 – 13:30Lunch & Networking
13:30 – 14:00Talk 4: Next-generation TCR-like antibodies with improved specificity profiles and drug-like properties for targeting of intracellular cancer antigensDr. Philipp Kuhn -YUMAB
14:00 – 14:45Talk 5: Streamlining Cell Therapy ManufacturingDr. Anil Kumar – ACROBiosystems
14:45 – 15:15Coffee Break
15:15 – 15:45Talk 6: Mastering biologics characterization and small molecules interactions with breakthrough biophysical methodsDr. Gianluca Russo -NanoTemper
15:45 – 16:15Talk 7: High-density peptide microarrays for epitope discoveryDr. Ebru Aydin Kurtulmus – Pepperprint
16:15Networking Apero

Topic:

Empowering the Research and Drug Development of Biomedicine

Introduction:

ACROBiosystems' symposium "Empowering the Research and Drug Development of Biomedicine" will be held at the Novartis Pavilion on September 24th.

The Novartis Pavilion, home to over 700 innovative pharma and biotech companies, is the perfect site to showcase cutting-edge life science developments and answer the big questions around the future of drug development. We'll take a deeper dive into the solutions and technology behind the drug development process; whether it starts from discovery & development or towards commercialization. By streamlining processes, accelerating breakthroughs, or ensuring regulatory compliance and final therapeutic safety, innovative technology is a driving force throughout the entire drug development process.

Our panel includes speakers from YuMAB, University of Bern, NanoTemper, Pepperprint, Medigene and ACROBiosystems that are dedicated towards providing solutions that empower research and development of biomedicines to advance healthcare.

Organiser

ACRO

ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine.

This web search service is supported by Google Inc.

totop

Nachricht schicken